首页 正文

Safety and Tolerability of PCSK9 Inhibitors: Current Insights

{{output}}
The current era of preventive cardiology continues to emphasize on low-density lipoprotein cholesterol (LDL-C) reduction to alleviate the burden of atherosclerotic cardiovascular disease (ASCVD). In this regard, the pharmacological inhibition of proprotein con... ...